Creatine Safety & Tolerability in Huntington's Disease
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to extend findings from the creatine dose-finding study
(CREST-UP1) in Huntington's disease to evaluate the long-term safety, tolerability, and
clinical impact of high dose creatine.